Markov influence diagrams (MIDs) are a new type of probabilistic graphical model that extends influence diagrams in the same way that Markov decision trees extend decision trees. They have been designed to build statetransition models, mainly in medicine, and perform costeffectiveness analyses. Using a causal graph that may contain several variables per cycle, MIDs can model various patient characteristics without multiplying the number of states; in particular, they can represent the history of the patient without using tunnel states. OpenMarkov, an open-source tool, allows the decision analyst to build and evaluate MIDs-including cost-effectiveness analysis and several types of deterministic and probabilistic sensitivity analysis-with a graphical user interface, without writing any code. This way, MIDs can be used to easily build and evaluate complex models whose implementation as spreadsheets or decision trees would be cumbersome or unfeasible in practice. Furthermore, many problems that previously required discrete event simulation can be solved with MIDs; i.e., within the paradigm of statetransition models, in which many health economists feel more comfortable.
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Influence diagrams (IDs) 2 are a form of PGM that, like decision trees, contains 3 types of nodes: chance, decision, and value. The main difference is that the graph of an ID is usually causal, and each variable (for example, a decision or the result of a test) is represented only once; whereas, in a decision tree, there are usually several nodes representing each variable in different scenarios. IDs are very compact and represent probabilistic independencies, and these advantages make it easier to build and maintain large decision models.
Cost-effectiveness analysis (CEA) with decision trees is complicated in problems that involve several decisions. Noticeably, embedded decision nodes-i.e., those that are not the root of the tree-may lead to the wrong results. 3 Having only one decision node (at the root of the tree) that represents all of the possible strategies, as recommended by Kuntz and Weinstein, 4 usually leads to huge decision trees, even for small problems. 3, 5 An algorithm proposed recently can perform CEA on trees with embedded decision nodes; 5 yet, the size of problems that can be represented is very limited. In contrast, IDs can solve very complex problems: Using an adapted version of the algorithm, we can perform CEA on 2 IDs whose equivalent decision trees would contain millions of branches. 6 CEA is even more difficult when time must be modelled explicitly. The most common approach is to build state-transition models 7-9 that allocate members of a population into one of several categories, or health states, and discretize time into a set of fixed-length intervals, called cycles, such that transitions between states can occur only at a certain moment in every cycle. Markov decision trees, originally called Markov cycle trees, 10 were the first representation used to implement state-transition models; other implementations use spreadsheets, discrete event simulation or computer programs, usually written in C++, R or BUGS; 11 each approach has pros and cons, as we discuss below.
In this paper, we introduce Markov influence diagrams (MID) as an extension of IDs, in the same way as Markov decision trees extend decision trees. The main difference is that IDs only contain atemporal variables-for example, the patients' gender-whereas MIDs also contain temporal variables, whose value evolves over time-for example, the age or the health state.
Due to the computational costs, MIDs containing temporal decisions can only be evaluated for very short horizons, as explained below. For this reason, we will assume that all decisions are atemporal, i.e., they are made at the beginning of the process; or they may be conditioned on future events (for example, ''do the test when the symptom is present''), but the policy is the same for all cycles. This way it is possible to evaluate MIDs with large horizons. To our knowledge, this restriction to atemporal decisions is also present in all models for CEA, including cohort models, patient-level simulation, and discrete event simulation. An important difference, however, is that cohort models usually represent the patient's state with a single variable and take on a limited number of values (states); consequently, there is often a need to multiply the number of states-for example, to represent the patient history. In contrast, patientlevel simulation, discrete event simulation, and MIDs can use several variables to model different characteristics of the health state. The main difference of IDs and MIDs with respect to the other types of models for CEA is the explicit use of a causal graph that represents all the variables and the relations among them. This graph facilitates the construction, debugging, and maintenance of the model, and the communication with experts-for example, with health technology assessment agencies.
Several example MIDs for medical problems are available on the Internet (see www.probmodelxml .org/networks). They were built with OpenMarkov (www.openmarkov.org), an open-source software package for MIDs that enables the user to perform cost-effectiveness analyses and several types of sensitivity analyses with a graphical user interface, without writing any code.
DEFINITION OF MID
An MID, like any other PGM, consists of a graph and a set of potentials. The graph depicts the causal relations between the variables, while the potentials encode the numerical parameters. In this section, we describe both elements of MIDs using, as an example, a model designed by Chancellor and others 12 to compare the cost-effectiveness of 2 anti-HIV therapies: lamivudine plus zidovudine (combination therapy) v. zidovudine alone (monotherapy). These therapies are now obsolete, but the model is still useful for didactic purposes. (An Excel version of this model can be found on the Web site for the book by Briggs and others 7 : www.herc.ox.ac.uk/ downloads/supporting-material-for-decision-modellingfor-health-economic-evaluation/ex47sol.xls).
In this model, the clinical condition of the patient is described by 4 possible states: State A, the least severe disease state, means that the CD4 count is between 200 and 500 cells/mm 3 ; State B means less than 200 cells/mm 3 ; State C represents AIDS; and the final state, D, represents death. The possible transitions are depicted as arrows in Figure 1 . The cycle length is 1 y. The effectiveness is measured as life duration, without considering the quality of life.
Qualitative Information: Structure of the Model
A graph consists of nodes and links. MIDs, like decision trees and influence diagrams, have 3 types of nodes: decision, chance, and value. If a node represents the value in the i-th cycle of a temporal variable, we write [i], as in Figure 2 .
Decision nodes represent choices available to the decision maker. They are drawn as rectangles. In Figure 2 , the decision node ''Therapy choice'' represents the selection of 1 of the 2 therapies under evaluation. This node has no index because, as said above, we assume that all the decisions are atemporal.
Chance nodes, drawn as rounded rectangles, represent all the properties that are not under the decision maker's control. In medical PGMs, they represent the patient's characteristics, such as sex, age, and health condition at a certain moment. (This is a difference with decision trees, which do not represent patients' baseline characteristics (for example, sex and age) as nodes but as parameters of the model.) Figure 2 contains 7 chance variables. State [0] represents the state of the patient in cycle 0 (start of therapy), with 4 values, 1 for each health state: A, B, C and D. State [1] represents the state of the patient in cycle 1 (1 y later) and has the same domain as State [0] . Time in treatment [0] and Time in treatment [1] are numeric variables that represent, for each cycle, how much time the patient has been receiving treatment. Therapy applied [i] represents the therapy applied in the i-th cycle, which can be combination therapy, monotherapy, or, if the patient is dead, none. Transition inhibited [1] indicates whether the addition of lamivudine has prevented a transition that would have occurred if the patient had received zidovudine (AZT) alone.
Value nodes represent the decision maker's payoffs, such as costs and health outcomes. They are drawn as hexagons. In Figure 2 , Life years [0] and Life years [1] represent effectiveness, whereas the other value nodes represent economic costs.
Nodes in an MID are connected by directed links. When there is a link X!Y, we say that X is a parent of Y. These links usually denote causal influence. For example, Therapy applied [i] depends on Therapy choice, on State [i] (because dead patients do not receive any therapy) and on Time in treatment [i] (because combination therapy is applied for a maximum of 2 y and then all patients receive monotherapy). State [1] depends on State [0] and on whether the transition has been inhibited. The effectiveness (Life years [i]), the direct medical costs, and the community care costs depend on the current state, whereas the cost of drugs depends on the therapy applied.
Quantitative Information: Numerical Parameters
An MID, like any other PGM for decision analysis, contains 2 types of numeric parameters: probabilities and values. Each chance or value node has an associated potential; i.e., a function that assigns a real number to each configuration of a set of variables. The potential for a chance node is a probability distribution for that variable conditioned on its parents in the graph. The potential for a value node is a function that indicates how this value depends on its parents.
A potential defined on a set of n discrete variables can be encoded as an n-dimensional table. (In this context, discrete is synonymous with categorical or finite-states. A numeric variable can be discretized by defining a finite set of intervals.) In our example, the probability distribution for node State [0], which has no parents in the graph, depends on no variable; i.e., it is the a priori probability P(State [0]). In a cohort interpretation of the model, this probability represents the proportion of individuals in each state at the beginning of the treatment. As this variable has 4 states, the probability can be represented by a 1D matrix (a vector) of 4 non-negative numbers, whose sum must be 1. The assumption that all the patients are initially in State A is encoded by setting the probability to 1 for this state and 0 for the others.
The probability of State [1] conditioned on its parents, State [0] and Transition inhibited [1] , can be represented by a 3D matrix, as shown in Figure 3 .
The potential for Figure 4 , which, in this case, does not contain any numeric information because the therapy applied depends deterministically on the 3 parents of this variable.
The probability distribution for Time in treatment [0] is a Dirac delta, because we know with certainty that the value of this variable is 0. Time in treatment [1] depends deterministically on its only parent, Time in treatment [0]; these 2 variables are related by a potential of type ''cycle length shift'', so that the value of Time in treatment [1] is the value of Time in treatment [0] plus the cycle length.
The variable Transition inhibited [1] represents the effect of combination therapy, which, in Chancellor's model, reduces the transition rate independently of the state of departure. Its probability is also represented by a table.
In the same way as every chance node has an associated conditional probability, every value node has a function that indicates how that value (the effectiveness or the cost) depends on its parents in the graph. In our example, these functions can be represented by tables because they are all defined on discrete variables.
BUILDING MIDS IN PRACTICE The Process of Building MIDs
An MID can be built by first drawing it on paper and then implementing it in a general programming language, such as C++, R or MATLAB. However, it is much easier to build it using a dedicated software package, such as OpenMarkov, because its graphical user interface facilitates the construction of the graph and the encoding of the potentials, and because this tool offers efficient evaluation algorithms, as explained below. [1] , conditioned on State [0] and Transition inhibited [1] . The leftmost column lists the parents of State [1] and the 4 possible values of this variable. When the transition has been inhibited, the patient remains in the same state as in the previous cycle. A red triangle denotes second-order uncertainty; in this example, there are 3 columns having each an associated Dirichlet distribution, which can be edited in a specific dialog.
The first step in the construction of an MID is selecting the variables and assigning a domain to each decision and each chance variable. Next, is to draw links among the nodes/variables, as explained above. Figures 5 and 6 show 2 MIDs containing 2 decisions (1 about a test and 1 about a treatment) and several chance nodes that represent the patient's personal characteristics, the health state, several symptoms, test results and therapies, and the possibility of healing because of a treatment. It also contains several value nodes that represent effectiveness (quality of life) and economic costs. Please note that all the links represent either causality or functional dependence.
The last step, the most difficult one, consists of assigning the potentials, especially those that contain numeric parameters. We have already mentioned 3 types of potentials: table, tree, and cycle length shift. There are 2 technical reports 15, 16 that describe in detail these and other types of relations and may serve as a guide for selecting the most appropriate representation for each potential depending on the type of variables involved, on the data available and, sometimes, on the modeller's preferences.
Representing the Patient's History in MIDs
This section illustrates, with 2 examples, the use of memory variables in MIDs to represent the patient's history without multiplying the number of states.
First Example: Duration of Stay in a Certain State
In some medical problems, the transition probabilities depend on how long the patient has been in a certain state. For example, the longer an HIV patient has had a low CD4 count (State B), the higher the probability of developing AIDS (State C) or dying (State D). Therefore, Chancellor's model can be refined by subdividing State B into 3 substates: B1, B2 and B3, such that B1 means that the patient has just entered State B; B2, that he entered State B in the previous cycle; and B3, that he has been in State B for at least 2 cycles. States B1 to B3 are called tunnel states because they can be visited only in a fixed sequence, 10 as shown in Figure 7 .
An alternative to using tunnel states is to represent the ''state'' with 2 variables: one for the clinical state-with 4 possible states: A, B, C and D, as in the original model-and the another for indicating how long the patient has been in the current state, as shown in Figure 8 . [i] has n values, this MID is equivalent to having 4ÁmÁn states; but its construction and maintenance is much easier than building a traditional model with lots of states, because the user does not need to think of all the possible combinations of the variables that jointly represent the patient's ''state''.
Second Example: Modeling Relapses
In some cases, the transition probabilities depend on the patient's entire history. For example, a more up-to-date model for HIV should allow backward transitions from State C (AIDS) to A or B, due to the efficacy of modern treatments; the probabilities of these transitions depend on how many times the patient has had AIDS. As in the previous example, this problem might be modelled by multiplying the number of states, such that they do not only represent the current health condition, but also the number of relapses, as shown in Figure 9 .
An alternative approach would be to have one variable representing the clinical state and another one representing the number of relapses, as in Figure 10 .
ALGORITHMS FOR MIDS
An MID can be converted into an ordinary ID by expanding it to the desired horizon and then evaluating it with the standard algorithms for IDs. For example, an MID containing only discrete variables-and numeric variables whose value is known with certainty, as in the HIV model-can be evaluated with the algorithm by Arias and Díez, 6 which computes the incremental cost-effectiveness ratios (ICERs) and the optimal strategy for each value of the willingness-to-pay. (A minor modification is necessary, however, for the efficiency of that algorithm: value nodes should be kept separate until the moment of eliminating the first decision, because, if we joined them into a single node when initializing the algorithm, the computational complexity would grow exponentially with the horizon.) If the MID has only one decision, this algorithm performs essentially the same operations as cohort evaluation, but it can also evaluate models containing several decisions, such as the examples in Figures 5 and 6. However, some MIDs having numerical variables may require patient-level simulation.
Similarly, it is possible to use variable elimination, a well-known algorithm for Bayesian networks and influence diagrams, 17 to compute and display graphically the temporal evolution of a variable, as shown in see Figure 1 . It is also possible to modify the parameters of the model and perform the same types of deterministic and probabilistic sensitivity analyses as with other types of models. Given that the optimal policy for a decision depends on all the variables known when making it, the complexity of these algorithms grows exponentially with the horizon for MIDs containing temporal decisions; whereas it grows only linearly when all the decisions are atemporal. For this reason, the MIDs presented in this paper and those available at www.probmodelxml.org/networks only have atemporal decisions, all of which can be evaluated with OpenMarkov in less than 10 sec.
COMPARISON OF MIDS WITH OTHER REPRESENTATION TECHNIQUES

MIDs v. Spreadsheet Models
The most common tool for implementing statetransition models is Excel, at least in Europe, 11 probably because this program is available in almost all computers, which avoids the need to buy dedicated software, and because it is relatively easy to write formulae in Excel. However, the more complex the model, the higher the skill in Excel needed, and the sensitivity analysis is usually implemented by Visual Basic macros, which also requires some knowledge of programming.
For a modeler, the main drawback is the need to encode the logic of the model in the form of sheets and formulae, which cannot be reused from other models. Additionally, in Excel models, the state must be represented by a single variable, because spreadsheets cannot deal with multidimensional matrices in a natural way. The only possibility of representing the patient's history is to subdivide the states, as explained above (see Figures 7 and 9) , and the more states in the model, the more difficult it is to build and maintain it. For this reason, when Hawkins and others 18 built a Markov model for the treatment of epilepsy, which needed to keep track of the time spent in the current state, they used R instead of Excel. In contrast, MIDs can represent the patient's history with one or several memory variables, without multiplying the number of states.
The problem with Excel models is not only the effort required to write the formulae but also the difficulty in uncovering the possible mistakes, because the formulae are more difficult to understand and debug than a piece of code written in a programming language. In fact, we detected minor bugs in 4 of the 5 Excel models that we translated into MIDs, even though their authors were in general experienced decision analysts. Fortunately, the impact of these bugs was irrelevant; but in other fields of scientific research, there are notorious examples of Excel bugs that lead to wrong conclusions. [19] [20] [21] In contrast, OpenMarkov's code is periodically tested using modern software-engineering techniques and tools, and the probability that the modeler makes a mistake when building a model with a graphical user interface is much smaller than when writing formulae and macros that mingle the model with the inference algorithm.
For an evaluation agency, the main advantage of a model implemented as a spreadsheet is that the same file contains the model, the code, and all the numerical results of its evaluation, thus making it possible to trace its execution step by step. However, the presence of complex formulae and Visual Basic macros makes it difficult to understand all the details of a model and check its correctness. Indeed, even though we had examined thoroughly the 5 Excel models when translating them into MIDs, we only discovered the bugs when comparing the numeric outputs of both versions of each model. As Drummond Rennie said, 22 ''Hill et al. 23 showed that it takes specially trained experts working whole time about two weeks to review CEAs provided by industry, even though these experts have all the information and have spreadsheets already in place. We agree with them that journal peer reviewers cannot possibly identify all the many serious problems, given their part-time approach.'' In contrast, MIDs are more transparent than spreadsheets because their causal graphs clearly show the structural assumptions and because the model can be inspected without reading a single line of code.
MIDs v. Markov Decision Trees
Both decision trees and IDs, as well as their Markov extensions, are based on graphs containing 3 types of nodes: chance, decision and value; Markov decision trees have a fourth type of node, called the Markov node. The main difference is that in (Markov) decision trees, the links outgoing from a node represent the states of the corresponding variable, while links in IDs and MIDs represent causal relations. In general, every variable appears several times in a decision tree, and the number of branches grows exponentially with the number of variables, which makes (Markov) decision trees inadequate for building large models. In contrast, in an MID, each variable can appear at most twice (once for each of the first 2 cycles), and it is therefore much more compact than the equivalent Markov decision tree, in the same way as every ID is much more compact than the equivalent decision tree. The reader can appreciate the difference by trying to mentally build a Markov decision tree for the MIDs in Figures 5 and 6 . For this reason, (M)IDs can solve much larger problems than (Markov) decision trees.
Additionally, when the dynamics of a model depends on the patient's history, Markov decision trees have only 2 possibilities: to multiply the number of states, as in Figures 7 and 9 , or to use socalled tracker variables. The first option leads to cumbersome models, just as when using Excel. The second requires patient-level simulation to evaluate the model, which often takes much longer than a cohort analysis. In contrast, many MIDs containing memory variables, including all the examples shown in this paper, can be efficiently evaluated with the algorithm by Arias and Díez. 6 Additionally, (M)IDs containing more than one decision are equivalent to (Markov) decision trees with embedded decision nodes, which cannot be evaluated with standard algorithms. 3 These are other reasons for which Markov decision trees are inadequate for large problems.
With respect to software tools, the main package for building (Markov) decision trees and performing cost-effectiveness analysis is TreeAge Pro, a mature commercial product. Older programs, such as WinDM and SMLTREE, are no longer available. OpenMarkov, in contrast, is still a research prototype; but, in addition to supporting MIDs and other types of probabilistic graphical models, it has the key advantage of being open-source, which implies that it can be used for free, and that its code can be inspected and extended to address the user's needs. Currently, TreeAge Pro offers many features not available in OpenMarkov but the latter has additional features not available in the former.
MIDs v. Programming Languages
Some state-transition models for cost-effectiveness analysis have been implemented in C++, MATLAB, R, or a language in the BUGS family, such as WinBUGS, OpenBUGS or JAGS. The main advantage of this approach is the possibility of implementing virtually any model and any evaluation algorithm. The drawback is that, as in the case of Excel, the model is mingled with the algorithm and everything must be programmed by the decision analyst, from the combination of transition probabilities to the sensitivity analysis and the graphical display of results.
In contrast, building, debugging, and evaluating an MID with OpenMarkov is much faster and easier but, as mentioned above, some models may contain features that are not yet available in this package, thus making it necessary to use a different modeling tool.
From the point of view of an evaluation agency, assessing the validity of a model encoded as a computer program may be difficult, especially if the code lacks a good design, clear in-line comments, and sufficient additional documentation.
Finally, we should mention that BUGS is especially suited for health technology assessment based on clinical trials because of its ability to integrate statistical inference and cost-effectiveness analysis; however, building and evaluating a model is much harder than when using OpenMarkov. We have begun researching the integration of these tools to combine the statistical power of the former with the facilities for model building and analysis of the latter; our goal is to use OpenMarkov to build the model, estimate its parameters from data (by connecting to some of the software packages in the BUGS family), and then perform cost-effectiveness and sensitivity analysis with the graphical user interface, without writing any code.
MIDs v. Discrete Event Simulations
Discrete event simulation (DES) is commonly used to model many entities that interact among themselves and with the environment; 24 for example, several individuals that can transmit an infectious disease to one another, or several beds in an emergency service that are to be occupied by patients who arrive randomly.
In the field of economic evaluation, some experts have argued that when a problem involves numeric variables or requires several variables to model the evolution of the patient, DES is more appropriate than a state-transition model. [24] [25] [26] [27] [28] [29] However, we have shown that MIDs can easily address these problems without abandoning the paradigm of state-transition models. Additionally, many MIDs-including all those mentioned in this paper-can be evaluated with cohort analysis, which is, in many cases, more efficient than patient-level simulation.
The main limitation of MIDs is the assumption of discrete time, whereas, in DES, time can be either discrete or continuous; however, it is unlikely that this difference may affect the conclusions of an economic evaluation. 24 In summary, some problems that were previously supposed to require DES can be analyzed with MIDs, thus maintaining all the advantages of statetransition models, which, according to a panel of experts, ''may be simple to develop, debug, communicate, and analyze, and they readily accommodate the evaluation of parameter uncertainty''. 30 
CONCLUSIONS
Markov influence diagrams (MIDs) are a new type of probabilistic graphical model especially designed for cost-effectiveness analysis with statetransition models. They extend influence diagrams in the same way as Markov decision trees extend decision trees.
We have argued that most state-transition models implemented as spreadsheets or Markov decision trees can be built much more easily using MIDs. In particular, MIDs can use memory variables to summarize the patient's history without multiplying the number of states.
In addition to using several variables to model the evolution of the patient, MIDs can also combine numeric and categorical variables in the same model, which are 2 of the advantages of DES. Therefore, MIDs can implement complex models that by far exceed the expressive power of spreadsheets without abandoning the paradigm of statetransition models, in which many health economists feel more comfortable.
For a decision analyst, building an MID and evaluating it with OpenMarkov is much easier and faster than implementing it as a spreadsheet, a Markov decision tree, or a computer program. This is particularly because its graphical user interface saves a lot of time and reduces the probability of making mistakes. Additionally, MIDs containing several decisions, such as the example in Figure 6 , can be evaluated with the algorithm by Arias and Díez, 8 which is difficult to implement in R or in another programming language, and virtually impossible in Excel or in patient-level simulation. However, there are other types of problems for which DES or dynamic transmission models are more adequate.
For an evaluation agency, understanding and assessing the correctness of an MID is much easier than for other types of models, for 2 reasons: because every MID is based on a causal graph that summarizes the structure of the model, and because it can be inspected separately from the software code used to evaluate it.
Most of the advantages of MIDs depend on the availability of software with a graphical user interface for building and evaluating them. The only one currently available is OpenMarkov, an open-source package. Therefore, in practice, the applicability of MIDs is limited by the facilities offered by this tool, which is still a research prototype. It already offers a wide range of potentials-including, for example, Weibull distributions and generalized linear models with fractional polynomials-and several types of deterministic and probabilistic sensitivity analyses. But if a problem required a feature not available in this tool, until that option is available, it would be impossible to build the model as an MID. Despite this, new features are constantly added to OpenMarkov, and other software packages might support MIDs in the future.
